Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2005; 11(45): 7118-7121
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7118
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7118
Table 1 Characteristics of patients at the beginning of the study
| Group 1 (5-ASA+ω-3) | Group 2 (5-ASA+placebo) | |
| Number of patients | 18 | 20 |
| Mean age (yr) | 9.33 | 10.85 |
| Sex (M/F) | 9/9 | 11/9 |
| Disease localization | ||
| Ileal | 10 | 7 |
| Ileo-colic | 6 | 8 |
| Colic | 2 | 5 |
- Citation: Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C, Diseases SISGOPIB. Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study. World J Gastroenterol 2005; 11(45): 7118-7121
- URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7118.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i45.7118